Adaptimmune Therapeutics plc (473A) — Tangible Net Worth Ratio
Adaptimmune Therapeutics plc (473A) has a Tangible Net Worth Ratio of 67.3% as of December 2024. This metric is calculated by deducting intangible assets (€3.88 Million) from net assets (€11.85 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Adaptimmune Therapeutics plc (473A) net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Adaptimmune Therapeutics plc Tangible Net Worth Ratio (2016–2024)
This chart shows how Adaptimmune Therapeutics plc's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of December 2024, the ratio stands at 67.3%, reflecting net assets of €11.85 Million with intangible assets of €3.88 Million EUR. Also explore 473A net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Adaptimmune Therapeutics plc (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Adaptimmune Therapeutics plc from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Adaptimmune Therapeutics plc.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 67.3% | €11.85 Million | €3.88 Million | €245.96 Million | ▼ -31.9 pp |
| 2023 | 99.2% | €39.51 Million | €330.00K | €282.62 Million | ▼ -0.3 pp |
| 2022 | 99.5% | €81.88 Million | €442.00K | €328.92 Million | ▼ -0.1 pp |
| 2021 | 99.5% | €205.96 Million | €1.00 Million | €469.55 Million | ▲ +0.0 pp |
| 2020 | 99.5% | €341.23 Million | €1.73 Million | €451.14 Million | ▲ +1.3 pp |
| 2019 | 98.2% | €123.64 Million | €2.20 Million | €181.54 Million | ▼ -1.2 pp |
| 2018 | 99.4% | €246.88 Million | €1.47 Million | €276.74 Million | ▲ +0.1 pp |
| 2017 | 99.3% | €202.98 Million | €1.34 Million | €281.15 Million | ▲ +0.1 pp |
| 2016 | 99.2% | €166.14 Million | €1.27 Million | €234.51 Million | — |